CD161/NK1.1 Antibody (PK-136) [DyLight 405] - Chimeric
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-20164V
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Cell depletion, Flow Cytometry
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # PK-136
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The original antibody was generated by immunizing (C3H X BALB)F1 mice with spleen cells enriched for NK-1 cells and bone marrow cells from CE mice.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Applications for CD161/NK1.1 Antibody (PK-136) [DyLight 405] - Chimeric
Application
Recommended Usage
Cell depletion
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD161/NK1.1
Alternate Names
Klrb1c, Ly-59, Ly55c
Gene Symbol
Klrb1c
Additional CD161/NK1.1 Products
Product Documents for CD161/NK1.1 Antibody (PK-136) [DyLight 405] - Chimeric
Product Specific Notices for CD161/NK1.1 Antibody (PK-136) [DyLight 405] - Chimeric
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...